Has Covid-19 impacted access to Parkinson’s medication?

News

Author: Simge Eva DoganPublished: 17 September 2020

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

New research has found that the coronavirus pandemic has affected access to medication for people living with Parkinson’s disease.

The sub-study used information from a survey conducted by the International Parkinson and Movement Disorder Society. The results from 346 participants showed that 22.8% of high-income and 88.9% of low-income countries’ respondents agreed that the coronavirus crisis had impacted people’s access to Parkinson’s medication. Some respondents reported increased disability, increased hospitalisation and increased mortality as factors. The majority of those who completed the survey were doctors.

The researchers concluded: “Our results offer preliminary data that the Covid-19 pandemic has affected Parkinson’s disease patients’ access to regular medication.

“Covid-19 has diverted resources away from chronic conditions towards the fight against Covid-19 in many countries. Resource-poor countries seem to be disproportionately affected compared to their affluent counterparts.”


Read more:

Brazilian dance could improve mobility in people with Parkinson’s, study finds

#WomenAndParkinsons shortlisted for ‘Charity Content Campaign of the Year’

Go Back

Share this story

Comments


Related articles


Parkinson's news

Global update

Five years of Parkinson’s campaigning

Parkinson’s Life sends its 250th newsletter

READ MORE
Tim Hague Parkinson's Vision 2020

Interviews

Young onset Parkinson’s: “How I look is not how I feel”

The first in our series profiling Parkinson's Vision 2020 speakers

READ MORE
170426_PL_Unity Walk New York lead

Global update

Every step counts: New York Unity Walk raises more than $1m for Parkinson’s

Twenty-third edition of world’s largest Unity Walk attracts 10,000

READ MORE